Actively Recruiting
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Led by Konkuk University Medical Center · Updated on 2026-03-03
76
Participants Needed
1
Research Sites
121 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine
CONDITIONS
Official Title
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled elective strabismus surgery aged 4-7 with American Society of Anesthesiologists (ASA) classification 1-3.
You will not qualify if you...
- ASA classification 3 or more
- Impaired liver function
- Impaired kidney function
- Myasthenia gravis or other neuromuscular disorders
- History of drug allergy
- Cardiovascular disease or arrhythmia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Konkuk University Medical Center
Seoul, Seoul-T'ǔkpyǒlshi, South Korea, 05030
Actively Recruiting
Research Team
Y
Yea-Ji Lee, M.D Ph. D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here